Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?

Background It is often stated that the lifetime risk of developing active TB after an index infection is 5% to 10%, one-half of which accrues in the 2 to 5 years following infection. The goal of this study was to determine whether such estimates are consistent with local programmatic data. Methods T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2016-02, Vol.149 (2), p.516-525
Hauptverfasser: Trauer, James M., MBBS, MPH, Moyo, Nompilo, MPH, Tay, Ee-Laine, MBBS, MPhil (App Epi), Dale, Katie, MClAud, MPH, Ragonnet, Romain, MS, McBryde, Emma S., PhD, Denholm, Justin T., PhD, MPH&TM
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 525
container_issue 2
container_start_page 516
container_title Chest
container_volume 149
creator Trauer, James M., MBBS, MPH
Moyo, Nompilo, MPH
Tay, Ee-Laine, MBBS, MPhil (App Epi)
Dale, Katie, MClAud, MPH
Ragonnet, Romain, MS
McBryde, Emma S., PhD
Denholm, Justin T., PhD, MPH&TM
description Background It is often stated that the lifetime risk of developing active TB after an index infection is 5% to 10%, one-half of which accrues in the 2 to 5 years following infection. The goal of this study was to determine whether such estimates are consistent with local programmatic data. Methods This study included close contacts of individuals with active pulmonary TB notified in the Australian state of Victoria from January 1, 2005, to December 31, 2013, who we deemed to have been infected as a result of their exposure. Survival analysis was first performed on the assumption of complete follow-up through to the end of the study period. The analysis was then repeated with imputation of censorship for migration, death, and preventive treatment, using local mortality and migration data combined with programmatic data on the administration of preventive therapy. Results Of 613 infected close contacts, 67 (10.9%) developed active TB during the study period. Assuming complete follow-up, the 1,650-day cumulative hazard was 11.5% (95% CI, 8.9-14.1). With imputation of censorship for death, migration, and preventive therapy, the median 1,650-day cumulative hazard over 10,000 simulations was 14.5% (95% CI, 11.1-17.9). Most risk accrued in the first 5 months after infection, and risk was greatest in the group aged < 5 years, reaching 56.0% with imputation, but it was also elevated in older children (27.6% in the group aged 5-14 years). Conclusions The risk of active TB following infection is several-fold higher than traditionally accepted estimates, and it is particularly high immediately following infection and in children.
doi_str_mv 10.1016/j.chest.2015.11.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1765113016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0012369215002494</els_id><sourcerecordid>1765113016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-992a4fbc84fa8c6876de4d5d50cbe49da177f8f0eac5075ee2f19c7d0b1aa9563</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EotvCL0BCviBxSfDEH4kPgKqKhUorIUE5cLIcZ0y9zcatvSnqv6_TLRy4oDmMRvO-M5pnCHkFrAYG6t22dpeY93XDQNYANYP2CVmB5lBxKfhTsmIMmoor3RyR45y3rNSg1XNy1KhOtR2XK7L5FvIVjZ6eun24RXox95jcPMYcMg0T3V8iXS-Nn2hTpus4jvF3mH7R88ljscSJ1g8B8s3HF-SZt2PGl4_5hPxYf7o4-1Jtvn4-PzvdVE6A2FdaN1b43nXC286prlUDikEOkrkehR4stK3vPEPrJGslYuNBu3ZgPVirpeIn5O1h7nWKN3NhYHYhOxxHO2Gcs4FWSQBeIBUpP0hdijkn9OY6hZ1NdwaYWTCarXnAaBaMBsAUjMX1-nHB3O9w-Ov5w60I3h8EWM68DZhMdgEnh0NIBYsZYvjPgg__-N0YpuDseIV3mLdxTlMhaMDkxjDzffnk8kiQjDVCC34PaJGXTw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765113016</pqid></control><display><type>article</type><title>Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Trauer, James M., MBBS, MPH ; Moyo, Nompilo, MPH ; Tay, Ee-Laine, MBBS, MPhil (App Epi) ; Dale, Katie, MClAud, MPH ; Ragonnet, Romain, MS ; McBryde, Emma S., PhD ; Denholm, Justin T., PhD, MPH&amp;TM</creator><creatorcontrib>Trauer, James M., MBBS, MPH ; Moyo, Nompilo, MPH ; Tay, Ee-Laine, MBBS, MPhil (App Epi) ; Dale, Katie, MClAud, MPH ; Ragonnet, Romain, MS ; McBryde, Emma S., PhD ; Denholm, Justin T., PhD, MPH&amp;TM</creatorcontrib><description>Background It is often stated that the lifetime risk of developing active TB after an index infection is 5% to 10%, one-half of which accrues in the 2 to 5 years following infection. The goal of this study was to determine whether such estimates are consistent with local programmatic data. Methods This study included close contacts of individuals with active pulmonary TB notified in the Australian state of Victoria from January 1, 2005, to December 31, 2013, who we deemed to have been infected as a result of their exposure. Survival analysis was first performed on the assumption of complete follow-up through to the end of the study period. The analysis was then repeated with imputation of censorship for migration, death, and preventive treatment, using local mortality and migration data combined with programmatic data on the administration of preventive therapy. Results Of 613 infected close contacts, 67 (10.9%) developed active TB during the study period. Assuming complete follow-up, the 1,650-day cumulative hazard was 11.5% (95% CI, 8.9-14.1). With imputation of censorship for death, migration, and preventive therapy, the median 1,650-day cumulative hazard over 10,000 simulations was 14.5% (95% CI, 11.1-17.9). Most risk accrued in the first 5 months after infection, and risk was greatest in the group aged &lt; 5 years, reaching 56.0% with imputation, but it was also elevated in older children (27.6% in the group aged 5-14 years). Conclusions The risk of active TB following infection is several-fold higher than traditionally accepted estimates, and it is particularly high immediately following infection and in children.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1016/j.chest.2015.11.017</identifier><identifier>PMID: 26867835</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Antitubercular Agents - therapeutic use ; Child ; Child, Preschool ; epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Morbidity - trends ; Prognosis ; Pulmonary/Respiratory ; Retrospective Studies ; Risk Assessment - methods ; Risk Factors ; Survival Rate - trends ; TB prevention ; Time Factors ; Tuberculosis, Pulmonary - epidemiology ; Tuberculosis, Pulmonary - prevention &amp; control ; Victoria - epidemiology</subject><ispartof>Chest, 2016-02, Vol.149 (2), p.516-525</ispartof><rights>American College of Chest Physicians</rights><rights>2016 American College of Chest Physicians</rights><rights>Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-992a4fbc84fa8c6876de4d5d50cbe49da177f8f0eac5075ee2f19c7d0b1aa9563</citedby><cites>FETCH-LOGICAL-c414t-992a4fbc84fa8c6876de4d5d50cbe49da177f8f0eac5075ee2f19c7d0b1aa9563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26867835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trauer, James M., MBBS, MPH</creatorcontrib><creatorcontrib>Moyo, Nompilo, MPH</creatorcontrib><creatorcontrib>Tay, Ee-Laine, MBBS, MPhil (App Epi)</creatorcontrib><creatorcontrib>Dale, Katie, MClAud, MPH</creatorcontrib><creatorcontrib>Ragonnet, Romain, MS</creatorcontrib><creatorcontrib>McBryde, Emma S., PhD</creatorcontrib><creatorcontrib>Denholm, Justin T., PhD, MPH&amp;TM</creatorcontrib><title>Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?</title><title>Chest</title><addtitle>Chest</addtitle><description>Background It is often stated that the lifetime risk of developing active TB after an index infection is 5% to 10%, one-half of which accrues in the 2 to 5 years following infection. The goal of this study was to determine whether such estimates are consistent with local programmatic data. Methods This study included close contacts of individuals with active pulmonary TB notified in the Australian state of Victoria from January 1, 2005, to December 31, 2013, who we deemed to have been infected as a result of their exposure. Survival analysis was first performed on the assumption of complete follow-up through to the end of the study period. The analysis was then repeated with imputation of censorship for migration, death, and preventive treatment, using local mortality and migration data combined with programmatic data on the administration of preventive therapy. Results Of 613 infected close contacts, 67 (10.9%) developed active TB during the study period. Assuming complete follow-up, the 1,650-day cumulative hazard was 11.5% (95% CI, 8.9-14.1). With imputation of censorship for death, migration, and preventive therapy, the median 1,650-day cumulative hazard over 10,000 simulations was 14.5% (95% CI, 11.1-17.9). Most risk accrued in the first 5 months after infection, and risk was greatest in the group aged &lt; 5 years, reaching 56.0% with imputation, but it was also elevated in older children (27.6% in the group aged 5-14 years). Conclusions The risk of active TB following infection is several-fold higher than traditionally accepted estimates, and it is particularly high immediately following infection and in children.</description><subject>Adolescent</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Morbidity - trends</subject><subject>Prognosis</subject><subject>Pulmonary/Respiratory</subject><subject>Retrospective Studies</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><subject>Survival Rate - trends</subject><subject>TB prevention</subject><subject>Time Factors</subject><subject>Tuberculosis, Pulmonary - epidemiology</subject><subject>Tuberculosis, Pulmonary - prevention &amp; control</subject><subject>Victoria - epidemiology</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EotvCL0BCviBxSfDEH4kPgKqKhUorIUE5cLIcZ0y9zcatvSnqv6_TLRy4oDmMRvO-M5pnCHkFrAYG6t22dpeY93XDQNYANYP2CVmB5lBxKfhTsmIMmoor3RyR45y3rNSg1XNy1KhOtR2XK7L5FvIVjZ6eun24RXox95jcPMYcMg0T3V8iXS-Nn2hTpus4jvF3mH7R88ljscSJ1g8B8s3HF-SZt2PGl4_5hPxYf7o4-1Jtvn4-PzvdVE6A2FdaN1b43nXC286prlUDikEOkrkehR4stK3vPEPrJGslYuNBu3ZgPVirpeIn5O1h7nWKN3NhYHYhOxxHO2Gcs4FWSQBeIBUpP0hdijkn9OY6hZ1NdwaYWTCarXnAaBaMBsAUjMX1-nHB3O9w-Ov5w60I3h8EWM68DZhMdgEnh0NIBYsZYvjPgg__-N0YpuDseIV3mLdxTlMhaMDkxjDzffnk8kiQjDVCC34PaJGXTw</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Trauer, James M., MBBS, MPH</creator><creator>Moyo, Nompilo, MPH</creator><creator>Tay, Ee-Laine, MBBS, MPhil (App Epi)</creator><creator>Dale, Katie, MClAud, MPH</creator><creator>Ragonnet, Romain, MS</creator><creator>McBryde, Emma S., PhD</creator><creator>Denholm, Justin T., PhD, MPH&amp;TM</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160201</creationdate><title>Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?</title><author>Trauer, James M., MBBS, MPH ; Moyo, Nompilo, MPH ; Tay, Ee-Laine, MBBS, MPhil (App Epi) ; Dale, Katie, MClAud, MPH ; Ragonnet, Romain, MS ; McBryde, Emma S., PhD ; Denholm, Justin T., PhD, MPH&amp;TM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-992a4fbc84fa8c6876de4d5d50cbe49da177f8f0eac5075ee2f19c7d0b1aa9563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Morbidity - trends</topic><topic>Prognosis</topic><topic>Pulmonary/Respiratory</topic><topic>Retrospective Studies</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><topic>Survival Rate - trends</topic><topic>TB prevention</topic><topic>Time Factors</topic><topic>Tuberculosis, Pulmonary - epidemiology</topic><topic>Tuberculosis, Pulmonary - prevention &amp; control</topic><topic>Victoria - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trauer, James M., MBBS, MPH</creatorcontrib><creatorcontrib>Moyo, Nompilo, MPH</creatorcontrib><creatorcontrib>Tay, Ee-Laine, MBBS, MPhil (App Epi)</creatorcontrib><creatorcontrib>Dale, Katie, MClAud, MPH</creatorcontrib><creatorcontrib>Ragonnet, Romain, MS</creatorcontrib><creatorcontrib>McBryde, Emma S., PhD</creatorcontrib><creatorcontrib>Denholm, Justin T., PhD, MPH&amp;TM</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trauer, James M., MBBS, MPH</au><au>Moyo, Nompilo, MPH</au><au>Tay, Ee-Laine, MBBS, MPhil (App Epi)</au><au>Dale, Katie, MClAud, MPH</au><au>Ragonnet, Romain, MS</au><au>McBryde, Emma S., PhD</au><au>Denholm, Justin T., PhD, MPH&amp;TM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>149</volume><issue>2</issue><spage>516</spage><epage>525</epage><pages>516-525</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><abstract>Background It is often stated that the lifetime risk of developing active TB after an index infection is 5% to 10%, one-half of which accrues in the 2 to 5 years following infection. The goal of this study was to determine whether such estimates are consistent with local programmatic data. Methods This study included close contacts of individuals with active pulmonary TB notified in the Australian state of Victoria from January 1, 2005, to December 31, 2013, who we deemed to have been infected as a result of their exposure. Survival analysis was first performed on the assumption of complete follow-up through to the end of the study period. The analysis was then repeated with imputation of censorship for migration, death, and preventive treatment, using local mortality and migration data combined with programmatic data on the administration of preventive therapy. Results Of 613 infected close contacts, 67 (10.9%) developed active TB during the study period. Assuming complete follow-up, the 1,650-day cumulative hazard was 11.5% (95% CI, 8.9-14.1). With imputation of censorship for death, migration, and preventive therapy, the median 1,650-day cumulative hazard over 10,000 simulations was 14.5% (95% CI, 11.1-17.9). Most risk accrued in the first 5 months after infection, and risk was greatest in the group aged &lt; 5 years, reaching 56.0% with imputation, but it was also elevated in older children (27.6% in the group aged 5-14 years). Conclusions The risk of active TB following infection is several-fold higher than traditionally accepted estimates, and it is particularly high immediately following infection and in children.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26867835</pmid><doi>10.1016/j.chest.2015.11.017</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2016-02, Vol.149 (2), p.516-525
issn 0012-3692
1931-3543
language eng
recordid cdi_proquest_miscellaneous_1765113016
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Adolescent
Antitubercular Agents - therapeutic use
Child
Child, Preschool
epidemiology
Female
Follow-Up Studies
Humans
Male
Morbidity - trends
Prognosis
Pulmonary/Respiratory
Retrospective Studies
Risk Assessment - methods
Risk Factors
Survival Rate - trends
TB prevention
Time Factors
Tuberculosis, Pulmonary - epidemiology
Tuberculosis, Pulmonary - prevention & control
Victoria - epidemiology
title Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A09%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Active%20Tuberculosis%20in%20the%20Five%20Years%20Following%20Infection%20.%20.%20.%2015%25?&rft.jtitle=Chest&rft.au=Trauer,%20James%20M.,%20MBBS,%20MPH&rft.date=2016-02-01&rft.volume=149&rft.issue=2&rft.spage=516&rft.epage=525&rft.pages=516-525&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1016/j.chest.2015.11.017&rft_dat=%3Cproquest_cross%3E1765113016%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1765113016&rft_id=info:pmid/26867835&rft_els_id=1_s2_0_S0012369215002494&rfr_iscdi=true